Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.068 AUD | -1.45% | -4.23% | -29.90% |
Apr. 05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
Feb. 26 | Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 1.56M 1.01M | Sales 2023 | 1.43M 930K | Capitalization | 23.45M 15.24M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.3M | Net income 2023 | -3M -1.95M | EV / Sales 2022 | 26.4 x |
Net cash position 2022 | 1.66M 1.08M | Net cash position 2023 | 3.94M 2.56M | EV / Sales 2023 | 13.6 x |
P/E ratio 2022 |
-15.4
x | P/E ratio 2023 |
-6.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.28% |
1 day | -1.45% | ||
1 week | -4.23% | ||
Current month | -16.05% | ||
1 month | -2.86% | ||
3 months | -29.17% | ||
6 months | -17.07% | ||
Current year | -29.90% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Miller
CEO | Chief Executive Officer | - | 02-06-20 |
Stephen Becker
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-16 |
Corporate Secretary | 67 | 99-02-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Thomas
BRD | Director/Board Member | 79 | 12-03-06 |
Michael Hoy
CHM | Chairman | 75 | 00-02-06 |
Michelle Miller
CEO | Chief Executive Officer | - | 02-06-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.068 | -1.45% | 828,126 |
24-04-23 | 0.069 | +1.47% | 328,410 |
24-04-22 | 0.068 | -2.86% | 1,072,433 |
24-04-19 | 0.07 | -1.41% | 832,718 |
24-04-18 | 0.071 | 0.00% | 547,392 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-29.90% | 40.35M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- BIT Stock